Is Parkway Life REIT A Good Buy In 2026 [Fundamental Analysis]

In this article, we'll be conducting a fundamental analysis of Parkway Life REIT and its suitability to achieve the following investment objective: To deliver a stable dividend yield of 5% to 6% per year while having a high degree of capital preservation ability.

Business Description

Parkway Life REIT is a Healthcare REIT that was listed in 2007 and owns hospitals and nursing homes across Singapore, Japan and France.

What I Like About Parkway Life:

• Management has grown the DPU sustainably which is a remarkable feat in the space of REITs
  

• Defensive industry with high downside protection to rental income
  

• Overall portfolio’s WALE is high and a high percentage of the leases have CPI-linked revision formulae and rent review provisions embedded in the tenancy contract.
  

• Management has consistently generated yield accretive capital recycling efforts over the past 18 years and has a clear strategic direction.

What I Do Not Like About Parkway Life:

• A good chunk of the revenue is subjected to foreign exchange risk (mainly Japanese Yen) which, while the demographic of future expansion/acquisition makes sense, brings about inevitable FX risks. While the management has displayed high levels of competence in managing the FX risks in the near term thus far, they will not be spared from long term structural trends.

Updates From Recent Performance (FY 2025)

General Comments:

• Gross revenue and Net Property Income increased by 7.6% & 8.0% y.o.y supported by stable operations from SG and Japan coupled with full year earning contributions from the newly acquired France portfolio.
  

• That said DPU increased around the usual range of 2.5% due to the enlarged unit base following the 2024 equity fund raising.
  

• Following the refinancing initiatives that is completed in Feb 2026, PLife will have no long-term debt refinancing needs till March 2027.

• Income hedges are secured till 1Q 2029 (JPY) and 1Q 2030 (EUR) ensuring stability in income distributions regardless of FX volatility.

• In 2025, PLife successfully executed the divestment of its Malaysian portfolio which accounted for 0.2% for portfolio value.

Positive Headwinds:

• Government fiscal spending towards healthcare across the world has been steadily increasing which provides a strong base case for continued operational stability of the healthcare operators as governmental subsidies continues to help press down the cost burden of personal health care consumption.

Negative Headwinds:

• The cost of borrowing of PLife REIT Japan borrowing is expected to increase once the existing fix rate matures in the next few years. For now though, the management has indicated that they expect its funding cost to remain stable in the near term.

Download Full Report On Telegram

and continue reading my independent analyst report which will provide you with a detailed look at the fundamentals of the stock and a range of price targets to help you out with your investment decision for ESR REIT:

*Join the channel → click on the channel name → under files → download the report you want!

If you would like to learn about REIT investing, you can find my entire methodology in my eBook: Retire With REITs here:

If you are looking for personalized financial advice, I offer a 1-to-1, fee-only consultation where you will receive personalized strategies to design, implement and manage a profitable REIT portfolio. You can find out more about it here:

Connect with me on social media platforms to receive updates on future content! You can also slide into my DMs if you have any questions :)

---

Disclaimer:

This article is meant to be the opinion of the author

This article is for information purposes only

This article should not be seen as financial advice

This advertisement has not been reviewed by the Monetary Authority of Singapore